Current Studies
Our portfolio includes a variety of marketed drugs such as Opzelura, Skyrizi, Otezla, Tremfya, as well as novel investigational drugs in various forms including topicals, oral medications, injectables, and IV therapies. We have conducted phase 1 through 4 trials for conditions such as psoriasis, eczema, hidradenitis suppurativa, vitiligo, lichen planus, alopecia, and more!
Status: RECRUITING
- Adult participants with hair loss affecting >50% of the scalp
- Amlitelimab monotherapy by subcutaneous injection (placebo-controlled)
If you are interested in participating, please click the gold ‘PARTICIPATE NOW’ button above.
You may also email research@apexskin.com or call us at 440-940-2739
Status: RECRUITING
- Adult participants with moderate-to-severe atopic dermatitis (eczema)
- Subcutaneous injection (placebo-controlled)
If you are interested in participating, please click the gold ‘PARTICIPATE NOW’ button above.
You may also email research@apexskin.com or call us at 440-940-2739
Status: RECRUITING in Canton and Mayfield Heights
- A study of Patidegib Gel 2% for the reduction of disease burden of persistently developing basal cell carcinomas in subjects with Gorlin Syndrome (placebo-controlled)
If you are interested in participating, please click the gold ‘PARTICIPATE NOW’ button above.
You may also email research@apexskin.com or call us at 440-940-2739
Status: RECRUITING
- IV Infusion of Vilobelimab for Ulcerative Pyoderma Gangrenosum (placebo-controlled)
If you are interested in participating, please click the gold ‘PARTICIPATE NOW’ button above.
You may also email research@apexskin.com or call us at 440-940-2739
Status: RECRUITING
- Subcutaneous injection for adult patients with moderate to severe hidradenitis suppurativa
- Placebo controlled for the first 16-weeks of treatment
- Possibility of receiving open label treatment for an additional 3 years
If you are interested in participating, please click the gold ‘PARTICIPATE NOW’ button above.
You may also email research@apexskin.com or call us at 440-940-2739
Status: RECRUITING
- Oral treatment for patients with moderate-to-severe Plaque Psoriasis (placebo-controlled)
If you are interested in participating, please click the gold ‘PARTICIPATE NOW’ button above.
You may also email research@apexskin.com or call us at 440-940-2739
Status: RECRUITING
- Chronic Spontaneous Urticaria
- Subcutaneous injection of Barzolvolimab (placebo-controlled)
If you are interested in participating, please click the gold ‘PARTICIPATE NOW’ button above.
You may also email research@apexskin.com or call us at 440-940-2739
APEX CLINICAL RESEARCH CENTER PROVIDES
Access to cutting edge clinical trials so that our patients can make a difference and can be a part of advancing the field of dermatology.
WHAT CONDITIONS DO WE WORK WITH?
- Atopic Dermatitis (Eczema) for adults and children
- Psoriasis for adults and children (various locations)
- Hidradenitis Suppurativa
- Gorlin Syndrome
- Pyoderma Gangrenosum
- Lichen Planus
- Vitiligo
- Prurigo Nodularis
- Alopecia
- Basal and Squamous Cell Carcinoma
- Seborrheic Keratosis
THE RESEARCH TEAM
We strive to leave no patient behind.
What Is Clinical Research?
All pharmaceutical medicines require a lengthy process of review before being approved by the FDA (U.S. Food and Drug Administration) for human use. This process can take many years as studies progress through the “phases." As opposed to “pre-clinical," the research is considered “clinical” once humans are included. Apex Dermatology’s Clinical Research Center partners with pharmaceutical companies to study the effectiveness and safety of newer dermatologic therapies. We aim to work with participants to advance medical treatments!
BLOG
Hope throughClinical Trials
Contact Us
Phone : 440-940-2739
Email : research@apexskin.com
Locations
Our main research center is inside our new, state-of-the art, medical building in Mayfield Heights, Ohio. We have approximately 2,000 square feet of space dedicated to research.
29111 Cedar Road Mayfield Heights, OH 44214
Apex Clinical Research is committed to bringing dermatological clinical trials to NE Ohio and plans to expand to additional clinics soon.